Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now later-stage tilt small index

Delayed Onset Muscle Soreness: later-stage trial registry

2 of 4 indexed Delayed Onset Muscle Soreness trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #4,115 of 28,707 conditions by registered trial count.

4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count

Delayed Onset Muscle Soreness: 4 US clinical trials tracked, 2 recruiting.

Delayed Onset Muscle Soreness is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Jean Brown Research, running 1 of these trials.

Enrollment posture brief

Registry condition delayed-onset-muscle-soreness

OPEN 2 | RECR 50% | LATE 2 | EARLY 0 | RANK #4115 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Delayed Onset Muscle Sor (th…50%
Open-enrollment share among volume-matched conditions near Delayed Onset Muscle Soreness

Delayed Onset Muscle Soreness lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Delayed Onset Muscle Soreness on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Delayed Onset Muscle Soreness is recruiting above its size-band peers.

    2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 42

Phase Distribution

PhaseTrial count
Phase 4 2

Named interventions

Most-linked intervention names on Delayed Onset Muscle Soreness records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

1% diclofenac sodium gel Drug
1 trials
Acetaminophen 1000mg Drug
1 trials
Blood Flow Restriction Device
1 trials
Pneumatic Compression Device
1 trials
Kinesiotape Device
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Delayed Onset Muscle Soreness trials. A trial with sites in several states counts in each.

California 2 trials
Utah 1 trials
Indiana 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Delayed Onset Muscle Soreness page

4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 2 Delayed Onset Muscle Soreness trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Jean Brown Research sponsors the most Delayed Onset Muscle Soreness trials on record, review their full trial history before evaluating a specific study. See Jean Brown Research's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Delayed Onset Muscle Soreness condition card totals 4 registered trials; most-linked intervention 1% diclofenac sodium gel; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.